Document is current
Any future updates will be listed below
-
Authors
García-Ruiz, S. https://orcid.org/0000-0003-4913-5312
Zhang, D.
Gustavsson, E. K. https://orcid.org/0000-0003-0541-7537
Rocamora-Perez, G.
Grant-Peters, M.
Fairbrother-Browne, A.
Reynolds, R. H. https://orcid.org/0000-0001-6470-7919
Brenton, J. W.
Gil-Martínez, A. L.
Chen, Z. https://orcid.org/0000-0001-6668-7202
Rio, D. C. https://orcid.org/0000-0002-4775-3515
Botia, J. A.
Guelfi, S.
Collado-Torres, L. https://orcid.org/0000-0003-2140-308X
Ryten, M. https://orcid.org/0000-0001-9520-6957
-
Funding
Funding for this research was provided by:
Michael J. Fox Foundation for Parkinson's Research (ASAP-000478, ASAP-000509, ASAP-000486)
RCUK | Medical Research Council (MR/N008324/1)
BrightFocus Foundation (A2021009F)
U.S. Department of Health & Human Services | National Institutes of Health (R01MH123567)
- License Information
-
More Information
Article History
Received: 11 April 2023
Accepted: 17 December 2024
First Online: 27 January 2025
Competing interests
: S.G. is a current employee of Verge Genomics. All work performed for this publication was performed in his own time, and not as a part of his duties as an employee. R.H.R and D.Z are current employees of CoSyne Therapeutics. All work performed for this publication was performed in their own time, and not as a part of their duties as employees. The remaining authors declare no competing interests.
